These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26085545)

  • 1. Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences.
    Conroy EJ; Harman NL; Lane JA; Lewis SC; Murray G; Norrie J; Sydes MR; Gamble C
    Clin Trials; 2015 Dec; 12(6):664-76. PubMed ID: 26085545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A third trial oversight committee: Functions, benefits and issues.
    Lane JA; Gamble C; Cragg WJ; Tembo D; Sydes MR
    Clin Trials; 2020 Feb; 17(1):106-112. PubMed ID: 31665920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials.
    Conroy EJ; Arch B; Harman NL; Lane JA; Lewis SC; Norrie J; Sydes MR; Gamble C
    Trials; 2017 Dec; 18(1):590. PubMed ID: 29221458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'We all want to succeed, but we've also got to be realistic about what is happening': an ethnographic study of relationships in trial oversight and their impact.
    Daykin A; Selman LE; Cramer H; McCann S; Shorter GW; Sydes MR; Gamble C; Macefield R; Lane JA; Shaw A
    Trials; 2017 Dec; 18(1):612. PubMed ID: 29273060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role and function of trial steering committees: results of an expert panel meeting.
    Harman NL; Conroy EJ; Lewis SC; Murray G; Norrie J; Sydes MR; Lane JA; Altman DG; Baigent C; Bliss JM; Campbell MK; Elbourne D; Evans S; Sandercock P; Gamble C
    Trials; 2015 Dec; 16():597. PubMed ID: 26715378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formalising the induction of patient and public involvement contributors on trial oversight committees.
    Pickering EC; Hanley B; Bell P; Gath J; Hanlon P; Oldroyd R; Stephens R; Tweed CD
    Res Involv Engagem; 2021 Jun; 7(1):42. PubMed ID: 34140027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trials.
    Coulman KD; Nicholson A; Shaw A; Daykin A; Selman LE; Macefield R; Shorter GW; Cramer H; Sydes MR; Gamble C; Pick ME; Taylor G; Lane JA
    Trials; 2020 Jun; 21(1):543. PubMed ID: 32552907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE) guidelines: a development protocol.
    Nagendrababu V; Duncan HF; Bjørndal L; Kvist T; Priya E; Pulikkotil SJ; Jayaraman J; Dummer PMH
    Int Endod J; 2019 Jul; 52(7):974-978. PubMed ID: 30702139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges.
    Daykin A; Selman LE; Cramer H; McCann S; Shorter GW; Sydes MR; Gamble C; Macefield R; Lane JA; Shaw A
    Trials; 2016 Jul; 17(1):307. PubMed ID: 27369866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data monitoring committees in pediatric randomized controlled trials registered in ClinicalTrials.gov.
    Machado T; Mainoli B; Caldeira D; Ferreira JJ; Fernandes RM
    Clin Trials; 2023 Dec; 20(6):624-631. PubMed ID: 37366168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data monitoring committees: Promoting best practices to address emerging challenges.
    Fleming TR; DeMets DL; Roe MT; Wittes J; Calis KA; Vora AN; Meisel A; Bain RP; Konstam MA; Pencina MJ; Gordon DJ; Mahaffey KW; Hennekens CH; Neaton JD; Pearson GD; Andersson TL; Pfeffer MA; Ellenberg SS
    Clin Trials; 2017 Apr; 14(2):115-123. PubMed ID: 28359194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing clustering effects and learning effects in the design and analysis of multicentre randomised trials: a survey to establish current practice.
    Conroy EJ; Blazeby JM; Burnside G; Cook JA; Gamble C
    Trials; 2020 May; 21(1):433. PubMed ID: 32460815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplies and equipment for pediatric emergency mass critical care.
    Bohn D; Kanter RK; Burns J; Barfield WD; Kissoon N;
    Pediatr Crit Care Med; 2011 Nov; 12(6 Suppl):S120-7. PubMed ID: 22067920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice guidelines for the maintenance of patient physical safety in the intensive care unit: use of restraining therapies--American College of Critical Care Medicine Task Force 2001-2002.
    Maccioli GA; Dorman T; Brown BR; Mazuski JE; McLean BA; Kuszaj JM; Rosenbaum SH; Frankel LR; Devlin JW; Govert JA; Smith B; Peruzzi WT;
    Crit Care Med; 2003 Nov; 31(11):2665-76. PubMed ID: 14605540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What information should a sponsor of a randomized trial receive during its conduct?
    Anand SS; Wittes J; Yusuf S
    Clin Trials; 2011 Dec; 8(6):716-9. PubMed ID: 22024103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size calculation for clinical trials: the impact of clinician beliefs.
    Fayers PM; Cuschieri A; Fielding J; Craven J; Uscinska B; Freedman LS
    Br J Cancer; 2000 Jan; 82(1):213-9. PubMed ID: 10638992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.